Expression of EGFRvIII and its coÔÇæexpression with wildÔÇætype EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

Ozlem Sherif; Said A. Khelwatty; Izhar Bagwan; Alan M. Seddon; Angus Dalgleish; Satvinder Mudan; Helmout Modjtahedi

doi:10.3892/or.2024.8831

Expression of EGFRvIII and its coÔÇæexpression with wildÔÇætype EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

Ozlem Sherif
, Said A. Khelwatty
, Izhar Bagwan
, Alan M. Seddon
, Angus Dalgleish
, Satvinder Mudan
, Helmout Modjtahedi

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	172
Journal	Oncology Reports
Volume	52
Issue number	6
Early online date	22 Oct 2024
DOIs	https://doi.org/10.3892/or.2024.8831
Publication status	Published - Dec 2024

Keywords

Cancer studies

Access to Document

10.3892/or.2024.8831

https://doi.org/10.3892/or.2024.8831

Cite this

Sherif, O., Khelwatty, S. A., Bagwan, I., Seddon, A. M., Dalgleish, A., Mudan, S., & Modjtahedi, H. (2024). Expression of EGFRvIII and its coÔÇæexpression with wildÔÇætype EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma. Oncology Reports, 52(6), Article 172. https://doi.org/10.3892/or.2024.8831

@article{2365a51431c74d84be893c9fbc3d1072,

title = "Expression of EGFRvIII and its co{\^O}{\c C}{\ae}expression with wild{\^O}{\c C}{\ae}type EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma",

keywords = "Cancer studies",

author = "Ozlem Sherif and Khelwatty, \{Said A.\} and Izhar Bagwan and Seddon, \{Alan M.\} and Angus Dalgleish and Satvinder Mudan and Helmout Modjtahedi",

year = "2024",

month = dec,

doi = "10.3892/or.2024.8831",

language = "English",

volume = "52",

journal = "Oncology Reports",

issn = "1021-335X",

publisher = "Spandidos Publications",

number = "6",

}

Sherif, O, Khelwatty, SA, Bagwan, I, Seddon, AM, Dalgleish, A, Mudan, S & Modjtahedi, H 2024, 'Expression of EGFRvIII and its coÔÇæexpression with wildÔÇætype EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma', Oncology Reports, vol. 52, no. 6, 172. https://doi.org/10.3892/or.2024.8831

Expression of EGFRvIII and its coÔÇæexpression with wildÔÇætype EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma. / Sherif, Ozlem; Khelwatty, Said A.; Bagwan, Izhar et al.
In: Oncology Reports, Vol. 52, No. 6, 172, 12.2024.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Expression of EGFRvIII and its coÔÇæexpression with wildÔÇætype EGFR, or putative cancer stem cell biomarkers CD44 or EpCAM are associated with poorer prognosis in patients with hepatocellular carcinoma

AU - Sherif, Ozlem

AU - Khelwatty, Said A.

AU - Bagwan, Izhar

AU - Seddon, Alan M.

AU - Dalgleish, Angus

AU - Mudan, Satvinder

AU - Modjtahedi, Helmout

PY - 2024/12

Y1 - 2024/12

KW - Cancer studies

U2 - 10.3892/or.2024.8831

DO - 10.3892/or.2024.8831

M3 - Article

SN - 1021-335X

VL - 52

JO - Oncology Reports

JF - Oncology Reports

IS - 6

M1 - 172

ER -